Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene  by Noiri, Eisei et al.
Kidney International, Vol. 56 (1999), pp. 74–82
CELL BIOLOGY – IMMUNOLOGY – PATHOLOGY
Reduced tolerance to acute renal ischemia in mice with a
targeted disruption of the osteopontin gene
EISEI NOIRI, KATE DICKMAN, FREDERICK MILLER, GALINA ROMANOV, VICTOR I. ROMANOV,
ROBERT SHAW, ANN F. CHAMBERS, SUSAN R. RITTLING, DAVID T. DENHARDT,
and MICHAEL S. GOLIGORSKY
Department of Medicine, The University of Tokyo, Tokyo Japan; Department of Medicine, VA Medical Center, Northport,
New York, USA; Division of Experimental Oncology, University of Western Ontario, London, Ontario, Canada; Department
of Life Sciences, Rutgers University, Piscataway, New Jersey, and Departments of Medicine, Physiology and Pathology,
State University of New York, Stony Brook, New York, USA
morphological sequelae of acute renal ischemia in opn 1/1Reduced tolerance to acute renal ischemia in mice with a tar-
and opn 2/2 mice provides strong evidence of renoprotectivegeted disruption of the osteopontin gene.
action of osteopontin in acute ischemia.Background. Mice with a targeted disruption of the osteo-
pontin gene through homologous recombination in embryonic
stem cells have recently been generated and shown to be char-
acterized by unaltered fertility and normal embryonic and post- Osteopontin, a negatively charged glycosylated phos-natal development, including renal development, but altered
phoprotein, has a broad tissue distribution. It is ex-osteoclastogenesis from spleen progenitors. The lack of detect-
pressed by different epithelial cells of the kidney, respira-able pathological manifestations in kidneys of mice with the
targeted disruption of the osteopontin gene (opn 2/2) makes tory, and gastrointestinal tract, frequently in association
them an excellent model for studies of pathophysiological pro- with their luminal surface, and by the cells of mesenchy-
cesses that are thought to be accompanied by changes in renal mal origin [1]. The protein is secreted and binds in theosteopontin expression. It has previously been suggested that
extracellular fluid to fibronectin and collagen [2, 3].osteopontin may play an important role in the pathophysiology
This protein contains a glycine-arginine-glycine-aspar-of acute renal failure, thus prompting this study.
Methods. Wild-type and opn 2/2 mice were subjected to tic acid-serine (GRGDS) sequence that is highly con-
30 minutes of renal ischemia and were studied 24 hours later. served among diverse species. This sequence is involved
Results. Control opn 1/1 mice showed a significant reten- in its binding to the aVb3 integrin receptor, thus promot-tion of blood urea nitrogen and creatinine, which is indicative
ing adhesion, spreading, and locomotion of several cellof the development of ischemic acute renal dysfunction. This
types [4, 5]. This sequence is predicted to be locatedwas accompanied by a 2.7-fold increase in the immunodetect-
able osteopontin compared with sham-operated control. Ani- in a b turn flanked by two b-sheet structures and is
mals with the disrupted osteopontin gene exhibited ischemia- presumably expressed unhindered for cell–matrix inter-
induced renal dysfunction, which was twice as pronounced as actions, which are both RGD and LM609 (an inhibitorythat observed in mice with the intact osteopontin response to
monoclonal antibody against the aVb3 integrin) inhibit-stress. In addition, the structural damage to the ischemic kid-
able [6].neys obtained from opn 2/2 mice was more pronounced than
that observed in similarly treated wild-type mice. This was Despite the significant progress in understanding the
associated with the augmented expression of inducible nitric structure and the topography of this phosphoprotein, its
oxide synthase and the prevalence of nitrotyrosine residues in functional role remains insufficiently understood. It haskidneys from opn 2/2 mice versus wild-type counterparts. In
been shown that the protein is elevated in some cancers,vitro studies with proximal tubular cells subjected to hypoxia
under the conditions of sepsis and inflammation, is accu-in the presence of OPN, but not OPN with deleted arginine-
glycine-aspartic acid (RGD) domain, resulted in cytoprotection. mulated at the sites of neointimal formation, and may
Conclusions. The comparative analysis of functional and participate in wound healing [reviewed in 7], giving rise
to the suggestion that osteopontin is important for tissue
repair and remodeling. Recently, the potential for osteo-Key words: acute renal failure, osteopontin, gene deletion, nitric oxide
synthase, nitrotyrosine. pontin-induced suppression of the inducible nitric oxide
synthase (iNOS) has been demonstrated [8], implyingReceived for publication May 6, 1998
its anti-inflammatory role. To gain further insight intoand in revised form February 1, 1999
Accepted for publication February 1, 1999 the function of osteopontin, we have used homologous
recombination in embryonic stem cells to generate mice 1999 by the International Society of Nephrology
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with a targeted disruption of the osteopontin gene [9]. was measured by colorimetric assay (Beckman synchron
CX and kit #443340). BUN was measured by the enzy-Using these mice, we attempted to address the role of
osteopontin in the ischemic injury to the kidney. matic conductivity rate method (Beckman synchron CX
and kit #443350). Sham-operated mice were subjectedIt has previously been demonstrated that the clamping
of the renal artery results in a profound elevation of to flank incision, mobilization of kidneys with decapsula-
tion, and served as control. Kidneys were harvested 24osteopontin expression along the entire nephron [10].
Studies from our laboratory have provided evidence that hours after clamp release, at the time of sacrifice, and
were fixed in 3.75% paraformaldehyde for the subse-RGD-containing peptides ameliorate the injury to ische-
mic kidneys by inhibiting conglomeration of desqua- quent immunofluorescence studies and in 10% formalin
for histochemistry. The second kidney was used to pre-mated tubular cells, thus preventing tubular obstruction,
and by interfering with polymorphonuclear leukocyte pare lysates, as detailed later in this article. There was
no mortality in the knockout or control group at 24adhesion to the endothelium, thus curtailing the sequelae
of leukocyte infiltration of the renal parenchyma [11, postoperative hours. In a separate series of experiments,
animals received an intraperitoneal injection of 5 mg/kg12]. Furthermore, our previous work has implicated the
activation of iNOS in the injury associated with renal LPS (from E. coli serotype 0127:B8, lot 63H4010) and
were processed similarly to those with renal ischemia.artery cross-clamping [13, 14]. These apparently distinct
phenomena could, in fact, represent separate links in
Western analysisthe common chain of cellular events characteristic of a
default renal response to ischemia-reperfusion. To eluci- Kidneys were removed, snap-frozen in liquid nitrogen,
and stored at 2708C. Thawed kidneys were homogenizeddate whether these events are indeed causally connected,
experiments with renal artery cross-clamping were per- using Tissue Tearor in 1 ml of extraction buffer [RIPA
buffer of the following composition: phosphate-bufferedformed in osteopontin knockout mice and their wild-
type counterparts, as summarized later in this article. saline (PBS) with 1% NP-40, 0.5% Na deoxycholate,
0.1% sodium dodecyl sulfate (SDS), 0.5 mm phenylmeth-
ylsulfonyl fluoride (PMSF), 1 mg/ml leupeptin, 1 mg/ml
METHODS
aprotinin, 10 mg/ml trypsin inhibitor, 1 mm Na orthovana-
Surgical procedures date] on ice. After clarifying the lysates and protein
quantitation by bicinchoninic acid (BCA) protein assayAll experiments were conducted in accordance with
the National Institutes of Health Guide for the Care and (Pierce, Rockford, IL, USA), protein concentration of
the lysates was adjusted to 7.5 mg/ml. Lysates wereUse of Laboratory Animals (U.S. Department of Health
and Human Services Public Health Services, National boiled for four minutes in sample buffer (3.5% sodium
dodecyl sulfate, 100 mm dithiothreitol, 0.02% bromphe-Institutes of Health, NIH Publication no. 86-23, 1985).
Five-week-old female mice (129xC57Bl/6 F2 strain serv- nol blue (BPB), 20% glycerol, and 60 mm Tris, pH 6.8).
The lysates were electrophoresed on 4 to 12% polyacryl-ing as wild-type and opn 2/2 mice) weighing 15 to 25 g
(mean 19 g) were allowed food and water ad libitum amide gel. After protein transfer to Immobilon-P mem-
branes (Millipore Corp., Bedford, MA, USA) in wetand were deprived of food for 12 hours prior to the
experiments. Animals were anesthetized with a combina- transfer system (Novex, San Diego, CA, USA), blots
were incubated in a blocking buffer (1% casein in phos-tion of ketamine hydrochloride 5.8 mg/100 g and xylazine
hydrochloride 0.39 mg/100 g. An intramuscular injection phate-buffered saline) for 30 minutes. Western blot anal-
ysis was performed with antibodies to either iNOS orof 250 units/kg heparin was given 15 minutes before the
operation. The animals were placed on a heated surgical nitrotyrosine (Transduction Labs, Lexington, KY, USA,
and Upstate Biotechnology, Lake Placid, NY, USA).pad. A 2.5 cm anterior midline incision was made. Renal
ischemia was started with clamping the renal pedicle of After blocking nonspecific binding and reaction with pri-
mary and secondary antibodies, labeled proteins wereboth right and left kidneys using microserrefines (FST,
Foster City, CA, USA). Renal surface temperature was visualized using an ECL chemiluminescence kit (Pierce)
and quantitated densitometrically.monitored by a spot thermometer (Minolta, Tokyo Ja-
pan) to control the quality of ischemia by changes in
Immunocytochemical analysisthe cortical surface temperature during clamping and
reperfusion. After 30 minutes, both clips were released, Immunocytochemical staining of 8 mm cryosections was
performed using indirect immunofluorescence technique.and the recovery of the blood flow was reconfirmed visu-
ally by the change in the color of the kidney cortex. The Sections were incubated for 60 minutes with primary
antibodies (0.5 mg/ml each) against iNOS or nitrotyro-incision was closed with a 6-0 suture and with Michel
miniature suture clips (FST). Blood was drawn at the sine residues, followed by the peroxidase- or fluorescein-
conjugated appropriate secondary IgG. Control sectionstime of sacrifice 24 hours after surgery for blood urea
nitrogen (BUN) and serum creatinine. Serum creatinine were subjected to the secondary antibody only. Mounted
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preparations were examined under a Nikon Diaphot epi- RESULTS
fluorescence microscope. Dynamics of OPN expression in hypoxic renal
proximal tubule epithelial cells
Antibodies and recombinant osteopontin
Based on the previous observations on the role of
Antibodies to iNOS and nitrotyrosine were purchased NO in epithelial cell damage, the role of OPN in the
from Transduction Labs and Upstate. Antisera raised inhibition of iNOS induction, and the presence of RGD
against osteopontin were obtained from Dr. L. Fisher domain within OPN, we addressed the role of hypoxia
(National Institutes of Health, polyclonal antisera #123 and hypoxia/reoxygenation in the induction of OPN and
and #124) [15] and Dr. G. Giachelli (University of Wash- iNOS. RPTECs were subjected to 12 to 24 hours of
hypoxia followed by 2 hours of incubation under theington, Seattle, WA, USA) [16]. Recombinant mouse
normoxic conditions. Cell lysates were prepared andosteopontin, as well as osteopontin with the site-directed
probed with antibodies to OPN and iNOS. As demon-deletion of the arg-gly-asp (RGD) sequence, was pro-
strated in Figure 1, both markers of proximal tubularduced according to the previously published protocol
epithelial cell injury were induced at 12 to 24 hours[17, 18] as glutathione transferase (GST) fusion proteins.
by these treatments: densitometric analysis showed that
OPN increased by 13, 34, 17, and 47%, and iNOS wasIn vitro studies with the recombinant and
increased by 33, 42, 85, and 73%, respectively. TheseRGD-deleted osteopontin
findings justified in vivo studies employing mice with aEstablished SV-40–immortalized cultures of human
deletion of the OPN gene, which were designed to eluci-
renal proximal tubule epithelial cells (RPTECs) (kindly
date the role of OPN in acute ischemic renal injury.
provided by Dr. L. Racusen, Johns Hopkins Medical
School) were maintained in a defined REGM medium In vivo role of OPN in acute renal ischemia:
(Clonetics, San Diego, CA, USA) and used at conflu- opn 2/2 mice
ency. Cells were subjected to hypoxia with the partial The renal function in experimental mice was examined
oxygen pressure of 30 barr for 12 to 48 hours, followed by determining plasma urea and creatinine concentra-
by two hours of incubation at normal oxygen pressure tions. Renal ischemia resulted in a significant elevation
in the presence of the recombinant osteopontin or osteo- of both parameters 24 hours after release of a renal
pontin with deleted RGD domain (1 mg/ml each); cyclic artery clamp in wild-type animals [BUN 132.4 6 23.2
RGDfV peptide was added to the RGD-deleted osteo- mg/dl, creatinine 0.97 6 0.14 mg/dl (mean 6 sem), N 5 7,
pontin at the concentration of 1 mg/ml. After completion P , 0.05] compared with sham-operated group (BUN
of hypoxic-normoxic incubation cycle, cells were stained 22.0 6 1.2 mg/dl, creatinine 0.17 6 0.02 mg/dl, N 5 6).
with ethidium homodimer and calcein-AM (live-dead However, both parameters showed a significant further
elevation in the osteopontin knockout group (BUNcell assay; Molecular Probes, Eugene, OR, USA) as per
210.2 6 19.9 mg/dl, creatinine 1.78 6 0.27 mg/dl, N 5 6,manufacturer’s instructions. Fluorescence of each fluor-
P , 0.05). As shown in Figure 2, the retention of BUNoprobe was detected using a fluorescence plate reader
and creatinine was twice as high in the knockout than(Cytofluor, PerSeptive Biosystems, Framingham, MA,
in the wild-type animals.USA), and the proportion of nonviable cells was compu-
Morphological analysis of ischemic kidneys revealedtated. Each determination was performed at least in qua-
a severe injury to the renal cortex and outer medulladruplicate in four separate experiments. In parallel
with the substantial tubular dilation and obstruction withexperiments, the proportion of apoptotic cells was calcu-
occasional sites of calcification seen in opn 2/2 mice, butlated after fixation with 2% glutaraldehyde and staining
to a much lesser degree in wild-type animals subjected toof cells with Hoechst 33342 used at the concentration of
ischemia of the same duration (Fig. 3). Comparative100 mg/ml (Molecular Probes).
analysis of the degree of injury was performed in a blind
fashion (scoring analogous to that presented in NoiriStatistical analysis
et al) [13] and demonstrated a statistically significant
The differences between experimental groups were difference in the degree of tubular necrosis (0.8 6 0.3,
analyzed using analysis of variance followed by the Bon- N 5 5, in wild-type vs. 2.0 6 0.0, N 5 3, in opn 2/2
ferroni test for post hoc analysis. A P value of less than mice, P , 0.05), with no other scoring variations between
0.05 was considered statistically significant. The number the groups. Kidneys from sham-operated animals, either
of animals used in each experimental series is detailed opn 1/1 or opn 2/2, showed no histological abnormali-
in the Results section. All data presented herein are ties detectable by the light microscopy.
representative of at least three to four separate experi- Immunohistochemical analysis comparing the distri-
bution of iNOS-immunoreactive material in knockoutments.
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Fig. 1. Expression of immunodetectable os-
teopontin and inducible nitric oxide (iNOS)
in hypoxic renal proximal tubular epithelial
cells. Analyses were carried out as detailed in
the Methods section. The membranes were
stripped and blotted with antibodies to tubulin
to confirm the uniformity of loading.
mice with their ischemic wild-type counterparts showed linked to the induction of iNOS, but required an addi-
tional oxidant-related stress [19].the intense staining of peritubular capillaries, some tubu-
lar epithelial cells in situ, and occasional cells occluding Western blot analysis of whole kidney lysates using
antibodies raised against osteopontin confirmed the ab-the tubular lumen (Fig. 4C). By comparison, opn 1/1
mice showed less intense staining of all these structures sence of immunodetectable protein in samples obtained
from knockout animals and showed a 2.7-fold increase(Fig. 4B). Antibodies to nitrotyrosine revealed the con-
spicuous labeling of vasae rectae, tubular epithelial cells, in kidneys with acute ischemic injury compared with
sham-operated control (Fig. 5A). At the same time, anti-and glomerular capillaries in opn 2/2 mice, whereas
their wild-type counterparts showed only a faint fluores- bodies against nitrotyrosine residues, as an indicator of
peroxinitrite production, revealed multiple immunoreac-cence of nitrotyrosine (data not shown). The expression
of iNOS in these kidneys displayed a 6.2-fold increase tive bands with the most prominent staining of a band
after acute ischemia, but iNOS expression was markedly with an apparent molecular weight of 55 to 57 kD. This
enhanced in opn 2/2 mice rendered ischemic (an 18- band displayed a higher abundance in kidneys obtained
fold increase compared with sham-operated controls, as from opn 2/2 animals subjected to renal ischemia com-
assessed densitometrically; Fig. 5B). pared with the ischemic wild-type mice (50% increase
In view of this dramatic expression of iNOS in ischemic vs. ischemic control; Fig. 5C). Neither control sham-
kidneys, an additional control series was introduced. We operated nor LPS-treated mice expressed substantial
argued that as long as the overexpression of iNOS plays amounts of immunodetectable nitrotyrosine (data not
a critical role in the postischemic renal injury, this effect shown).
could be reproduced in its entirety by the cytokine-
In vitro studies on the role of OPN in cell viabilityinduced overexpression of the enzyme. For this purpose,
opn 1/1 and opn 2/2 mice were injected intraperitone- To address the possible role of RGD domain of OPN
in kidney resistance to ischemia (compared with the kid-ally with 5 mg/kg lipopolysaccharide (LPS) or with the
equal volume of vehicle. Twenty-four hour postinjection neys from opn 2/2 mice), experiments were performed
in cultured human proximal tubular cells subjected to aanimals showed no changes in plasma BUN and creati-
nine (28 6 3.5 and 0.2 6 0.1, N 5 6, in wild-type vs. 24-hour cycle of hypoxia followed by a 2-hour incubation
in a normoxic environment. Cells were incubated in the30 6 5 and 0.15 6 0.05 mg/dl, N 5 5, in opn 2/2 mice)
and displayed a comparable degree of expression of im- presence of either the recombinant OPN or OPN with
deleted RGD domain (1 mg/ml each) [17, 18]. In a sepa-munodetectable iNOS in kidney lysates using Western
blot analysis and on staining with antibodies to iNOS rate series of experiments, cells incubated with OPN
lacking the RGD domain received an additional supple-(not shown). These findings are reminiscent of those
obtained by Peresleni et al, who demonstrated that cyto- ment with the cyclic RGDfV peptide at the concentration
of 1 mg/ml, which has previously been found to affordtoxicity in renal tubular epithelia could not be solely
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DISCUSSION
The comparative analysis of functional and morpho-
logic sequelae of acute renal ischemia in wild-type and
opn 2/2 mice provided strong evidence of renoprotec-
tive action of osteopontin. Animals with the disrupted
osteopontin gene exhibited the degree of ischemia-
induced renal dysfunction, as judged by the retention of
BUN and creatinine, which was twice as pronounced as
that observed in mice with the intact osteopontin re-
sponse to stress. In addition, the structural damage—
tubular necrosis—to the ischemic kidneys obtained from
opn 2/2 mice was more pronounced than that observed
in similarly treated wild-type mice. Collectively, these
data implicate the lack of osteopontin in the reduced
renal tolerance of acute ischemia.
In the previous studies of acute renal ischemia, the
up-regulation of osteopontin was appreciated [10], and
the investigators envisioned its potential renoprotective
role in acute renal injury. One of the hypotheses ascrib-
ing such a role to osteopontin was based on the fact
that this secretory product contains an arginine-glycine-
aspartic acid (RGD) motif. Previous studies from our
laboratory have established the protective effect of an
injected cyclic RGD peptide [11, 12] and suggested that
the RGD-containing peptide, by virtue of its binding
to several integrin receptors, prevents the adhesion of
desquamated tubular epithelial cells within the tubular
lumen, thus preventing tubular occlusion. In addition, it
attenuated an in vitro leukocyte-endothelial cells interac-
tion, thus raising the possibility that it could inhibit leu-
Fig. 2. Retention of blood urea nitrogen and creatinine in experimental kocyte diapedesis. Hence, it is possible that osteopontin
animals 24 hours after acute renal ischemia. The number of animals exerts its renoprotective effect via the RGD-dependent
studied was as follows: 8, ischemia in wild-type (Control ischemia); 7,
mechanism.ischemia in knockout (knockout ischemia); and 4, sham surgery (Sham
operation) in wild-type mice. *Significant difference (P , 0.05) between An alternative explanation of the observed intoler-
control ischemic and sham-operated groups; **significant difference ance of opn 2/2 mice to acute renal ischemia may stem
(P , 0.05) between knockout ischemic and control ischemic groups.
from the recently described inhibitory action of osteo-
pontin on iNOS [8, 20, 21]. Indeed, both the in vitro and
in vivo observations in ischemic kidneys implicated the
increased production of NO in the injury to the tubular
epithelium [13, 14], and the degree of injury was found
renoprotective effect [11, 12]. Figure 6A summarizes the to be substantially lower in mice lacking iNOS [22]. Per-
results of a live-dead assay to quantitate the population esleni et al demonstrated that overproduction of NO
of nonviable cells. Hypoxia-reoxygenation resulted in alone could not account for the observed injury and
increased proportion of dead cells, which was not af- presented evidence that the combination of reduced oxy-
fected by the fusion protein GST alone (data not shown). gen and nitrogen intermediates [19], resulting in the gen-
Recombinant OPN-GST fusion protein consistently re- eration of peroxinitrite [23, 24] and possibly other cyto-
duced the proportion of dead cells. This cytoprotective toxic substances, is responsible for the loss of cell
effect was absent in experiments when the RGD lacking viability. It is, therefore, conceivable that osteopontin
OPN was added to the incubation medium. Combining knockout may be accompanied by reduced tolerance to
it with the soluble cyclic RGD peptide restored cytopro- acute ischemia because of the lack of its inhibitory action
tection of OPN-RGD(2). Similarly, the proportion of on the iNOS, and as the consequence, the unrestrained,
apoptotic cells was reduced by the addition of OPN to by this particular mechanism, cytotoxic effect of reduced
the incubation medium, and the combination of cyclic oxygen and nitrogen intermediates.
RGD peptide with OPN-RGD(2) reproduced the effect These questions were addressed using a recently de-
veloped mouse model with targeted disruption of theof the intact OPN (Fig. 6B).
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Fig. 3. Representative images of structural abnormalities in ischemic
kidneys. 1. (A) 3125 Hematoxylin and eosin. (B) 3300 Hematoxylin
and eosin stain. Severe acute tubular necrosis with extensive coagulative
necrosis (microinfarction) typical of the knockout ischemic kidneys is
shown. 2. (A) 3125 Hematoxylin and eosin, and (B) 3300 Hematoxylin
and eosin stain. Moderate geographic acute tubular necrosis with casts,
shed tubular epithelium and mild edema characteristic of the wild-type
ischemic animals can be seen. 3. (A) 3125 Hematoxylin and eosin, and
(B) 3300 hematoxylin and eosin. Normal kidney as seen in sham-
operated knockout and wild-type animals.
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Fig. 5. Expression of osteopontin, iNOS, and nitrotyrosines in the kid-
ney. (A) Western blot analysis of osteopontin expression. Experiments
were performed with four different antibodies; two antibodies, antisera
#123 and #124, were kindly provided by Dr. L. Fisher. One was gener-
ated against osteopontin in knockout mice, and one was kindly provided
by Dr. C. Giachelli. Only the results obtained with the latter are pre-
sented, although other antibodies resulted in a similar immunodetection
pattern. (B, C) Western blot analysis of iNOS and nitrotyrosine expres-
sion. Only two representative samples each are illustrated. Analyses
were performed as detailed in the Methods section. Abbreviations are:
Sh, sham operated; WT, wild-type; KO, knockout; LPS, lipopolysaccha-
ride.
notype was recently reported by another group that
demonstrated that osteopontin as well as osteopontin/
vitronectin double knockout mice are fertile and do not
carry any overt abnormalities, but exhibit altered wound
healing [25]. Immunocytochemical and immunoblotting
studies in control and ischemic mice (Figs. 4 and 5) con-
firmed the expected absence of osteopontin in knockout
animals. The lack of significant pathological manifesta-
tions in mice with the targeted disruption of osteopontin
gene makes them an excellent model for studies of patho-
physiological processes that are thought to be accompa-
nied by changes in osteopontin expression. Indeed, theFig. 4. Immunocytochemical detection of iNOS in the kidney. Cryosec-
application of such a model may assist in assigning totions were stained with monoclonal antibodies to iNOS and were
revealed using horseradish peroxidase-conjugated goat antimouse sec- osteopontin a role of an active modulator of or a passive
ondary antibodies, as detailed in the Methods section. (A) Control bystander in these processes.sham-operated kidney. (B) Ischemic kidney obtained from opn 1/1
To test the possibility of unrestrained induction ofmouse. Note the staining of peritubular capillaries and occasional tubu-
lar epithelial cells. (C) Ischemic kidney obtained from opn –/– mice. iNOS, we performed Western analysis of kidney lysates
Note the intense staining of peritubular capillaries, tubular epithelial and immunohistochemical studies of kidney sections ob-cells, and desquamated epithelial cells obstructing tubular lumen (mag-
tained from wild-type and opn 2/2 animals. The ob-nification 3200).
served differences were consistent with this possibility
of the disproportionately high induction of iNOS in
knockout animals. This was further buttressed by the
osteopontin gene [9]. This has been successfully accom- detection of nitrotyrosine residues, a fingerprint of per-
plished by homologous recombination in embryonic oxinitrite generation. Kidneys from opn 2/2 mice
stem cells resulting in the generation of an opn 2/2 showed enhanced staining of multiple bands, and espe-
genotype that showed unaltered fertility and normal em- cially prominent among them was an approximate sev-
bryonic and postnatal development, but altered osteo- enfold increase in the expression of an immunodetect-
able product with a molecular weight of 55 to 57 kDa.clastogenesis from spleen progenitors [9]. A similar phe-
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drawal of serum [26]. In view of the recent demonstration
of the anti-apoptotic action of NF-kB via suppression of
caspase-8 activation [27], the observed effect of OPN
could be, in part, explained by this mechanism. Further-
more, the hyaluronan receptor CD44, which is thought
to be an alternative receptor to OPN, is expressed de
novo by tubular epithelial cells at sites of injury in a
murine model of tubulointerstitial nephritis and overex-
pression of OPN colocalizes with CD44 [28]. Collec-
tively, these data could explain the ability of OPN to
afford cytoprotection through integrin and, possibly,
nonintegrin receptors. The specific functional role of
other domains of OPN in modulating renal epithelial
cell viability remains to be elucidated.
Being produced and secreted by various cell types,
including renal fibroblasts, osteopontin is found in differ-
ent body fluids [5, 29], where it modulates cell adhesion
and locomotion [30–32]. This phosphoprotein, in addi-
tion to its prevalent localization to the bone matrix, has
been found to be overexpressed at sites of granuloma-
tous inflammation, in various tumors, in atherosclerotic
plaques [29], as well as in glomerulosclerosis and in inter-
stitial fibrosis [16, 33, 34]. The protein is induced by
bacterial endotoxins [35] and by renal ischemia [10], in
which it is believed to play a role in protecting the kidney.
Osteopontin participates in the metanephric develop-
ment when it appears to contribute to the tubulogenesis
[36]. Based on these observations, it has been hypothe-
Fig. 6. Viability of proximal tubular cells subjected to 24-hour hypoxia sized that osteopontin, rather than being a bystander,and 2-hour normoxia in the presence of OPN and OPN with deleted
plays a critical role in protecting the kidney against ische-RGD domain, OPN (RGD–). (A) Comparison of the cytoprotective
effects of OPN and OPN-RGD(2) with and without added cyclic RGD mia and/or accelerating the recovery process [10]. The
peptide. (B) The effect of OPN and OPN-RGD(–) with and without data presented in this communication support such aadded cyclic RGD peptide on apoptosis in proximal tubular cells. The
view. Animals with the targeted deletion of osteopontindata are (mean 6 sd, N 5 4 to 6) representative of three similar
experiments performed in cells on different passages. *Significant differ- gene are characterized by the enhanced sensitivity to
ence from control (P , 0.05); **significant difference from OPN (P ,
acute renal ischemia. This sensitization to ischemia/0.05).
reperfusion correlates with iNOS induction and peroxi-
nitrite formation. In vitro findings point to a role of RGD
domain of OPN in affording cytoprotection. It remains
In vitro studies have provided additional support to to be seen whether OPN has a role in epithelial regenera-
the acute cytoprotective effect of OPN and provided tion after renal ischemia and whether other organs of
some insights into the possible mode(s) of OPN action. opn 2/2 mice, for example, the brain or the myocar-
Indeed, recombinant osteopontin added to the incuba- dium, display a similar sensitization to the ischemia/
tion medium of renal proximal tubular cells subjected reperfusion injury.
to hypoxia reoxygenation resulted in cytoprotection. Os-
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